Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Debt / NOTE 1.500% 4/1
-
Number of holders
-
25
-
Total 13F principal, excl. options
-
172,807,000
-
Principal change
-
+172,807,000
-
Total reported value, excl. options
-
$177,229,715
-
Value change
-
+$177,229,715
-
Number of buys
-
25
-
Price
-
$1.02
Significant Holders of COHERUS BIOSCIENCES INC - NOTE 1.500% 4/1 as of Q2 2021
25 filings reported holding 19249HAB9 - COHERUS BIOSCIENCES INC - NOTE 1.500% 4/1 as of Q2 2021.
COHERUS BIOSCIENCES INC - NOTE 1.500% 4/1 has 25 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $172,807,000 of principal
.
Largest 10 bondholders include Opti Capital Management, LP ($29,150,000 of principal), UBS ASSET MANAGEMENT AMERICAS INC ($26,000,000 of principal), LAZARD ASSET MANAGEMENT LLC ($17,500,000 of principal), CITADEL ADVISORS LLC ($15,950,000 of principal), DEUTSCHE BANK AG\ ($15,024,000 of principal), CNH PARTNERS LLC ($14,645,000 of principal), D. E. Shaw & Co., Inc. ($10,500,000 of principal), WOLVERINE ASSET MANAGEMENT LLC ($8,500,000 of principal), WELLS FARGO & COMPANY/MN ($7,605,000 of principal), and CALAMOS ADVISORS LLC ($5,467,000 of principal).
This table shows the top 25 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.